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Abstract
Background—This report describes the resources required to support the integrated approach of 
the Barbados National Registry for Chronic Non-communicable Diseases (BNR) to non-
communicable disease (NCD) case registration, and to identify differences in cost for collecting 
and maintaining information on cancer and cardiovascular disease (CVD) case registration.
Methods—We used the modified Centers for Disease Control and Prevention’s International 
Registry Costing Tool to collect data from the CVD and cancer registries. We used cancer and 
CVD cost data for the annual period April 2014 through March 2015 to estimate the total cost and 
cost per case. We used prospectively collected average annual CVD cases, and for cancer cases we 
assumed 2 or 3 years are needed for retrospective data collection.
Results—The Ministry of Health provided 56% of the resources for the registries. Labor 
accounted for over 70% of both registries’ budgets, while management and administration, along 
with data collection and analysis, incurred the highest costs per case. Total variable cost activities 
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related to data collection and analysis were higher for the CVD component (US$131,297) than the 
cancer component (US$58,917). The CVD cost per case (US$489) was in between the cancer 2-
year (US$382) and the cancer 3-year (US$573) cost-per-case estimates.
Conclusion—These findings indicate that there are substantial fixed costs related to 
management and administration of NCD registries. All registries need management and 
administration support. When registries are combined, management and administration costs can 
be shared. We project that registries that can share fixed-cost infrastructure are likely to incur a 
lower total cost per case.
Keywords
Non-communicable disease registries; Cancer; Cardiovascular disease; Economic evaluation; 
Activity-based cost
1. Introduction
The Caribbean Community (CARICOM) has the highest prevalence of non-communicable 
diseases (NCDs) in the Americas, causing much premature loss of life, lost productivity, and 
spiraling healthcare costs [1]. It is expected that NCD deaths in this region will increase by 
17% over the next 10 years, and predictions for the ensuing two decades include a near 
tripling of ischemic heart disease and stroke mortality [2]. In response to this epidemic, the 
CARICOM Heads of Government demonstrated their commitment to combat NCDs through 
the Port-of-Spain Declaration, which strongly encouraged the establishment of National 
Commissions on NCDs to plan and coordinate the prevention and control of NCDs, 
surveillance systems, and research programs in collaboration with universities [3].
Barbados is a high-income island nation in the Caribbean, with an area of 432 square 
kilometers (166 square miles) [4] and a population of 277,821 (in 2010), of which 92% are 
black [5]. In response to the Port-of-Spain declaration, the Ministry of Health established the 
National NCD Commission and contracted the University of the West Indies (UWI) to 
manage a population-based, multi-NCD surveillance system on its behalf, and with 
oversight from the Commission: the Barbados National Registry for Chronic NCD (the 
BNR). The BNR was launched in 2007 through initial funding from the European 
Development Fund; it comprises three registries: BNR-Cancer, BNR-Stroke, and BNR-
Heart. The registries collect data on new cases of cancer, stroke, and acute myocardial 
infarction, respectively, and produce statistics concerning incidence, mortality, and survival. 
The BNR registries were implemented in stages to allow adequate time for planning each 
type of data collection. The start-up phase required substantial investment in hiring and 
training personnel, and time to ensure that appropriate support infrastructure was available to 
initiate data collection, perform quality review, and implement initial registry findings to 
further improve the registration procedures. The phased introduction began in July 2008 
with BNR-Stroke, followed by BNR-Heart in July 2009 and BNR-Cancer in July 2010. 
Barbados does not have a coordinated electronic health information system, and case reports 
require abstracts from mostly paper-based patient records.
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Population-based NCD registries are important for measuring trends, epidemiological 
research, public health planning, evaluation of prevention and control programs, and patient 
care improvement processes [6]. Although the importance of population-based NCD 
registries to a country is readily justifiable, such registries involve cost and may not be 
sustainable during times of economic constraint. The aim of this study is to identify 
differences in the resources used to operate a cancer registry and CVD registry in Barbados, 
and to suggest areas that could improve registry efficiency. For policy-makers who make 
decisions about budgets for public health activities, economic evaluation of registries helps 
to document the resources required to sustain registration activities. Additionally, cost 
assessment can be used to improve cost effectiveness and efficiency-of-registry operations 
[7,8]. In addition, details on the cost of the BNR approach for collecting data on cancer and 
cardiovascular diseases (CVDs) such as stroke and acute myocardial infarction (heart attack) 
may help inform other countries developing plans to establish NCD registries.
2. Methods
2.1. Registry data collection approach
The data collection mandates, methods, and operational processes for the BNR, as well as 
the details on the data elements collected, have been described previously [9]. The BNR 
registration activities are designed to meet specific objectives identified as key areas of 
importance in NCD surveillance in Barbados. The BNR reporting obligations are listed 
below.
1. Total number of case registrations expressed as a proportion of the population 
(%).
2. Total number of hospital admissions for cancer or CVD events expressed as a 
proportion of the number of registrations (%).
3. Total number of cancer or CVD events expressed as a proportion of the number 
of case registrations (%).
4. Average length of hospital stay (in days) for cancer or CVD events.
The BNR-Stroke and BNR-Heart currently use a mixture of active and passive case-finding, 
and follow similar data-collection approaches. After cases are verified as eligible for 
registration, BNR staff abstract the patient notes and then enter that information into the 
registry database. One set of data abstractors collects the required data elements for both 
stroke and heart-attack events. These data elements include treatment, date of last contact, 
and status of last contact at patient follow-up (28 days and 1 year post-event). BNR-Cancer 
follows different requirements and has a separate dedicated team of data abstractors. To 
facilitate the analysis presented in this study, we report data for BNR-Cancer and a 
consolidated CVD component (BNR-CVD) with combined information for the stroke and 
heart-attack registries.
Table 1 shows the differences between the CVD and cancer-registry data collection 
procedures. The CVD component (BNR-Heart and BNR-Stroke) identifies incident cases 
prospectively on a continuing annual basis, and follows the World Health Organization 
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STEPwise approach to stroke surveillance (WHO STEPS), which involves collecting data 
from hospitals, the national death registration system, and the community [10]. The cancer 
component (BNR-Cancer) identifies incident cases collected retrospectively (for one specific 
year), generally from hospitals, laboratories, and the national death registration system. 
BNR-Cancer follows the processes created by the International Agency for Research on 
Cancer (IARC) [11] and collects the recommended minimum data elements, such as 
treatment, date of last contact, and status at last contact, using the established definitions. 
For the first year of data collection, the cancer registry collected data on all types of skin 
cancers, including non-melanoma; however, for the second year, the registry collected data 
only on melanomas. The second year of data is still under internal review processes and has 
not yet been through internal or external validation for quality and completeness.
As further described in Table 1, the BNR-CVD and BNR-Cancer registries differ not only in 
their data collection approach but also in all the processes used to capture the data elements. 
The number of data elements collected for each stroke and heart attack case is about four 
times higher than the number for cancer cases; however, for cancer cases, more sources are 
visited, and many more suspected-patient notes are reviewed to register a case. Two 
abstractors are assigned to cancer, compared with four for the CVD registries, and cancer 
cases do not require active follow-up data collection, as is done for the CVD registry 
components.
Despite these differences, several key activities are shared across the registries. These 
include administration, management, data analysis and tabulation, database management, 
quality assurance, and community outreach and training. All registry staff share a common 
space, infrastructure, and communication tools.
2.2. Cost data collection approach
We used the modified Centers for Disease Control and Prevention’s (CDC’s) International 
Registry Costing Tool (IntRegCosting Tool) to collect cost data from the BNR-CVD and 
BNR-Cancer registry components [12]. The tool was originally designed to collect cost data 
from cancer registries, and was modified to collect data from the Barbados NCD registry 
with integrated cancer and CVD registry activities. In each of the ten modules of the 
IntRegCosting Tool we provide separate categories to report cost and resource-use data 
specific to each registry component. When there were shared expenditures across registries, 
we provided an option for reporting the proportion of the cost that was allocated to each. For 
example, when labor was shared, the time spent on each registry activity by component was 
used to assign the proportion of cost. For rental cost of shared space, the proportional cost 
was based on the number of square feet used.
We collected the cost data from the perspective of the registry, and therefore collected data 
on all resources required to support registry operations. These sources included financial 
support as well as non-monetary contributions from the host institution, the Chronic Disease 
Research Centre (CDRC) of the UWI. We used financial records from the BNR and CDRC 
to determine the registry’s incomes and expenditures from April 2014 to March 2015. We 
asked registry and CDRC personnel to account for their registry-specific activities within 
and across registries (where applicable) using percentages. All registry staff were able to 
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allocate their time to the standardized set of registry activities provided in the IntRegCosting 
Tool. The User’s Guide provided with the tool offered guidance on completing the tool 
along with definitions for the standard set of activities.
3. Calculations
On the basis of the allocation provided in the IntRegCosting Tool, we assigned cost by 
budget categories to BNR-CVD and BNR-Cancer. We categorized cost into registry staff, 
consultants, materials and travel, and administrative or indirect costs. Additionally, we 
assigned resources to each activity performed by the registry; labor costs were allocated on 
the basis of the proportion of time spent on each activity and registry (cancer or CVD). To 
accurately estimate cost of labor, salary information was available for each registry staff 
member. Similarly, we assigned the non-labor resources component to each activity and 
registry, and we used “best-case” estimates to determine the value of non-monetary 
contributions using previously tested economic methods [13–15].
At the time of the initiation of BNR-Cancer (2010), at least 2 years post-diagnosis was 
needed to allow for complete data to be available, including treatment information. 
Therefore, the first year of data collected was for patients diagnosed in 2008. The 2008 
cancer-case data were collected over a 3-year period (2011 through 2014), which represents 
the start-up phase of the cancer registry. We believe that in the future, as the registry 
becomes more established, it will take less time to collect a single year of incidence data, 
because the initial requirements – intensive staff training and time required to work out 
details on specific data collection procedures – will not be needed. If additional data, such as 
stage at diagnosis, are collected in the future, then staffing needs will change. We present 
both an established phase estimate and start-up phase estimates for the cancer cases, which 
reflect collection of a single year of incident cases over a 2-year versus a 3-year period. The 
cases reported for BNR-CVD and BNR-Cancer are used as the denominator value in 
calculating the cost per case, that is, the estimated cost to the registry to report one incident 
case. We report the total cost per case as well as the cost per registry activity to allow us to 
systematically compare the BNR-Cancer and BNR-CVD operations. For conversion from 
Barbadian dollars (BD$) to US dollars (US$), we used 1 US$ = 2 BD$.
4. Results
The total expenditure for the BNR for the annual period from April 1, 2014 to March 31, 
2015 was BD$1,128,907 (US$564,453). Financial resources from the Ministry of Health 
comprised 56% of the resources, for a total of BD$634,321 (US$317,161), and the 
remaining resources comprised contributions from the host institution, UWI’s CDRC (data 
not shown). Fig. 1 illustrates the distribution-by-budget category for BNR-Cancer and BNR-
CVD. Both registries had a similar distribution, with registry labor incurring the highest 
proportion of the cost at 71% and 75% for BNR-Cancer and BNR-CVD, respectively. BNR-
Cancer used 23% of resources for administrative or indirect costs, and BNR-CVD used 
16%; other costs related to consultants, materials, and travel made up less than 10% of the 
total cost for both registry components.
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Fig. 2 shows the 13 registry activities and administration-related costs reported during this 
period for both registry components. For cancer, we report both an established phase and a 
start-up phase cost-per-case estimate, which reflects collection of 1 year of incidence data 
over a 2-year or 3-year period, respectively. Overall, the top four highest-cost activities for 
both BNR registry components were management, administration, data collection, and data 
analysis and tabulation. For the fixed-cost activities – for example, cost of management and 
administration –that will not vary with the volume of cases registered over the short term, 
the BNR-CVD and the low-cost BNR-Cancer were generally quite similar. The 3-year BNR-
Cancer estimates were higher. Among the variable cost activities that depend on the volume 
of cases: (1) BNR-CVD incurred higher costs than BNR-Cancer for data collection and 
database management; (2) BNR-CVD incurred costs between the start-up phase cost and 
established phase cost for BNR-Cancer for data analysis and tabulation; and (3) BNR-CVD 
had a lower cost than BNR-Cancer for quality assurance.
Table 2 presents the total cost per case for each of the BNR registry components. The cost 
per case for BNR-Cancer was BD $764 (US$382) when data collection was done over a 2-
year period and BD$1146 (US$573) when data collection required a 3-year period. The cost 
for collecting and reporting one case was BD$978 (US$489) for the BNR-CVD registry.
5. Discussion
This paper provides the results and lessons learned from the economic evaluation carried out 
on the BNR operations using the IntRegCosting Tool. A substantial proportion of the 
registry operations expenditure is related to staff employed by the registry, reflecting the 
labor-intensive nature of collecting and reporting incidence cases worldwide, Europe 
included [12,16,17]. The cost per cancer case for the BNR-Cancer registry (US$382–US
$573) is six to nine times higher than the cost per cancer case collected by the registries 
funded by the CDC; the average cost per case for the US registries is about US$61 [7,8], 
with low-volume registries incurring a higher cost per case than high-volume registries. The 
cost per cancer case for the BNR-Cancer registry is higher than the average cost per cancer 
case collected by European registries, which is about US$70 [17]. The cost is also 
significantly higher than the cost-per-case registries in low- and middle-income countries 
(LMICs) studied by Tangka et al., which ranged from US$4 (Mumbai, India) to US$113 
(Pasto, Colombia) [16]. There are several potential reasons for the BNR-Cancer’s costs 
being comparatively higher than those of US and LMIC registries. The Barbados registries 
are in the early stage of operation, with some start-up-related activities still ongoing (for 
example, optimization of the data collection approach), collection of a small volume of cases 
(larger volumes result in economies of scale), and the facing of additional challenges in data 
collection, including the need to abstract much of the data from paper records.
The data from the BNR has not yet undergone quality and completeness checks to be 
included in Cancer Incidence in Five Continents. Although cancer is a reportable disease, 
passive notification from private physicians remains low; after BNR staff visits to 
physicians, however, there was some improvement. Currently, the team uses active 
surveillance by performing regular call-rounds to all private physicians known to diagnose 
cancer patients, as well as by collecting information from laboratories and the national death 
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register. Additionally, BNR team members are working with the Ministry of Health to revise 
pathology regulations to allow notification of all suspected and confirmed cancer cases 
directly to BNR by laboratories island-wide [9].
The BNR-Cancer performs only retrospective data collection (no change in the data-
collection approach is currently planned), whereas the BNR-CVD collects data 
prospectively for a much larger set of data elements on a daily basis, and is also engaged in 
active post-event follow-up of patients. Given these differences, we would expect that the 
BNR-Cancer cost per case would be substantially lower than that of BNR-CVD. There are 
several potential explanations as to why we did not find substantially lower costs for BNR-
Cancer estimates. First, we report the total cost, which includes both the fixed and the 
variable costs. When we separate these costs, we find that the variable components of CVD, 
such as data collection and database management, are higher than those for cancer. Second, 
much of the cost for both the CVD and cancer registries is cost associated with management 
and administration. For the cancer registry, which was initiated after the CVD registry, we 
assume that many fixed costs related to these activities were already present. Therefore, the 
addition of the cancer registry (incremental cost) increased only the variable components, 
including the need to assign additional data abstractors. In this instance, the addition of the 
cancer registry to an already existing infrastructure did not result in a much lower cost per 
case.
Although there are potential efficiencies related to collecting data on diagnosis, treatment, 
and outcomes retrospectively for a specific year of cancer diagnosis (over a 2-year or 3-year 
period), economies of scale can also occur with simultaneous collection of multiple years of 
cancer incidence data. This is because, during data collection for only a specific year, 
abstractors ignore data that they come across for cancers not diagnosed during the year of 
interest. In contrast, for multiple years, during any data-collection visit abstractors collect all 
cancer cases regardless of the year of diagnosis; for the latter, it is the reporting, not the 
abstraction, that is driven by year of diagnosis. With retrospective data collection, at least in 
some instances, patient records may not be as easily accessible as prospective data 
collection, because medical charts for patients who have completed treatment may have been 
archived. BNR-Cancer has chosen to focus on a 2-year or 3-year retrospective period 
because of the lack of resources to hire adequate staff and provide other non-labor resources 
to collect cancer-case incidence on a continuous basis. To facilitate future planning, a 
comparative study could be performed on the resources needed for abstraction of a single 
year of cancer cases diagnosed versus multiple years of cancer cases diagnosed, abstracted 
on a continuous basis.
Although there is no coordinated electronic health information system in Barbados, the BNR 
is making efforts to improve efficiency in data collection. The BNR-Cancer process involves 
data input from patient records directly into an electronic database, and the BNR-CVD is 
moving toward more electronic data capture, with the aim of eliminating paper-based data 
collection. The lessons learned thus far include the need to allow for a significant amount of 
time for staff training and implementation because of the steep learning curve involved in 
converting from paper to an all-electronic format. In addition, the ability to navigate between 
data elements or sections may be more cumbersome with electronic data sheets than with 
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paper forms. In the future, the BNR surveillance cost may be lower with the introduction of 
the proposed electronic health information systems throughout the island. Such a system 
could allow for enhanced direct electronic data capture from the hospital medical department 
records and databases, but there could also be unanticipated issues related to data quality 
that will need to be carefully reviewed before full-scale use by the registry.
The BNR operations are complex, entailing multiple registries with differences in data-
collection approaches. In this study we have attempted to use standardized definitions to 
enable comparison between BNR-Cancer and BNR-CVD registry cost components. A 
potential limitation stems from the differences in procedures that may lead to variation in 
how resources – such as staff time – are allocated to registry activities. Additionally, we 
collected only 1 year of cost data from the BNR, which is usually funded in 3-year cycles. 
There may be year-to-year variations that were not captured using the single year of data 
reported in this study. Finally, the BNR is still in the early phase of data collection, 
especially in terms of cancer cases, and therefore data-collection procedures and other 
registration processes may evolve over time as lessons learned are incorporated to further 
improve the efficiency of registry operations.
The data from the BNR have been used to inform national guidelines on death-certification 
data quality, as well as to provide the evidence for the opening of a cardiac suite and acute 
stroke unit at the only national public hospital on the island. BNR data will be used to 
evaluate the outcomes of these two critical care wards in the near future. Additionally, BNR 
has been instrumental in improving patient care through its biannual training seminars 
targeting medical doctors and nurses.
The BNR is a unique, multi-NCD registry that collects information on cancer, stroke, and 
heart attack. Although their data collection approaches differ, the BNR-CVD and BNR-
Cancer registries share management resources and other fixed costs such as office space. 
Intuitively, this could have resulted in efficiencies, but we were unable to systematically 
assess the potential cost effectiveness of integrating multiple registry operations within a 
single entity. Future studies need to be designed to quantify potential efficiencies, as the 
findings will be very valuable for other small-island nations that are in the process of 
planning the structures of their NCD surveillance operations.
6. Conclusions
This study illustrates how economic evaluation can provide evidence for making decisions 
about funding and operational efficiency to ensure that the BNR can operate sustainably and 
continue to make important contributions to improving the quality of care in Barbados. The 
registry, especially BNR-Cancer, is still in the early stages of implementation. The findings 
from this study and lessons learned from ongoing data-collection efforts will allow BNR-
Cancer to optimize operations.
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Fig. 1. 
Barbados Registries’ resources by budget categories, April 1, 2014–March 31, 2015. BNR, 
the Barbados National Registry for Chronic Non-communicable Disease; CVD, 
cardiovascular disease.
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Fig. 2. 
Barbados Registries’ cost per case by activity, April 1, 2014–March 31, 2015. Cancer cases 
were collected retrospectively over multiple years, and therefore we present an established-
phase estimate and a start-up-phase estimate for cost per case assuming a 2- or 3-year period 
for data collection. The established phase cost-per-case estimate corresponds to the 2-year 
period of data collection, and the start-up-phase cost-per-case estimate is for the 3-year 
period. For cardiovascular disease (CVD), we report an annual estimate using the average 
monthly cases based on 2013 and 2014 incident cases. 1 United States dollar (US$) = 2 
Barbadian dollars (BD$). BNR, the Barbados National Registry for Chronic Non-
communicable Disease.
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Table 1
Differences between the cancer- and cardiovascular-disease-registry components of the Barbados National 
Registry, April 1, 2014–March 31, 2015.
Cancer registry Cardiovascular disease registries
Data collection approach Retrospective Prospective
Data capture process Direct data entry using laptops Paper case-reporting form; scanned into database
Number of data elements collecteda 187 1563 (stroke: 729, heart: 834)
Average number of data sources visited to register one 
case
5 2
Average number of suspected-patient notes investigated 
to register one confirmed case
15 5 (heart); 1.5 (stroke)
Number of data abstractors 2 4
Patient follow-up Passive follow up with Death-
record linkage
Active case follow up
a
The data elements collected include the treatment variable.
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Table 2
Barbados Registry cases and cost per case.
Cancer (BNR-cancer) Cardiovascular (BNR-CVD)
Established phase (cases collected 
over 2 years)
Start-up phase (cases collected 
over 3 years) Average
Incident cases collected (per 
year)a
602 cases 401 cases 684 cases
Cost per caseb,c BD$764 BD$1146 BD$978
BNR, the Barbados National Registry for Chronic Non-communicable Disease; CVD, cardiovascular disease.
a
There were 1204 total cancer incidence cases during 2008. Cancer cases were collected retrospectively over multiple years, and therefore we 
present an established phase estimate and a start-up phase estimate for cost per case assuming a 2- or 3-year period for data collection. The 
established phase cost-per-case estimate corresponds to the 2-year period of data collection, and the start-up phase cost-per-case estimate is for the 
3-year period. For CVD, we report an annual estimate using the average monthly cases based on 2013 and 2014 incident cases.
bCost per case is defined as the total costs by cancer or CVD registry for the reporting period divided by the incident cases collected during the 
reporting period.
c1 United States dollar (US$) = 2 Barbadian dollars (BD$).
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